Global Cord Blood (CORBF) Stock Statistics & Valuation Metrics
Total Valuation
Global Cord Blood has a market cap or net worth of $127.35M. The enterprise value is -$5800.29T.
- Market Cap
- $127.35M
- Enterprise Value
- -$5800.29T
Share Statistics
Global Cord Blood has 133,914,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 133,914,720
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Global Cord Blood’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.26%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 6.26%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 1.03M
- Profits Per Employee
- 416.86K
- Employee Count
- 1,202
- Asset Turnover
- 0.15
- Inventory Turnover
- 4.00
Valuation Ratios
The current PE Ratio of Global Cord Blood is 1.53. Global Cord Blood’s PEG ratio is -0.20.
- PE Ratio
- 1.53
- PS Ratio
- 0.68
- PB Ratio
- 0.16
- Price to FCF
- 1.43
- Price to Operating Cash Flow
- 1.25
- PEG Ratio
- -0.20
Income Statement
In the last 12 months, Global Cord Blood had revenue of 1.24B and earned 501.06M in profits. Earnings per share was 4.12.
- Revenue
- 1.24B
- Gross Profit
- 1.06B
- Operating Income
- 608.87M
- Pretax Income
- 627.84M
- Net Income
- 501.06M
- EBITDA
- 656.79M
- Earnings Per Share (EPS)
- 4.12
Cash Flow
In the last 12 months, operating cash flow was 161.70M and capital expenditures 0, giving a free cash flow of 161.70M billion.
- Operating Cash Flow
- 161.70M
- Free Cash Flow
- 161.70M
- Free Cash Flow per Share
- 4.89
Dividends & Yields
Global Cord Blood pays an annual dividend of $0.08, resulting in a dividend yield of ―
- Dividend Per Share
- $0.08
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 70.17%
- Earnings Yield
- 65.23%
Stock Price Statistics
- Beta
- -0.61
- 52-Week Price Change
- 26.80%
- 50-Day Moving Average
- 0.95
- 200-Day Moving Average
- 0.96
- Relative Strength Index (RSI)
- 44.69
- Average Volume (3m)
- 5,855
Important Dates
Global Cord Blood upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- ―
- Next Earnings Date
- ―
- Ex-Dividend Date
- Jul 27, 2018
Financial Position
Global Cord Blood as a current ratio of 10.73, with Debt / Equity ratio of 0.00%
- Current Ratio
- 10.73
- Quick Ratio
- 10.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -10.14
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Global Cord Blood has paid 118.35M in taxes.
- Income Tax
- 118.35M
- Effective Tax Rate
- 0.19
Enterprise Valuation
Global Cord Blood EV to EBITDA ratio is -8.85, with an EV/FCF ratio of -9.79.
- EV to Sales
- -4.68
- EV to EBITDA
- -8.85
- EV to Free Cash Flow
- -9.79
- EV to Operating Cash Flow
- -9.48
Balance Sheet
Global Cord Blood has $1.05B in cash and marketable securities with $23.00K in debt, giving a net cash position of $1.05B billion.
- Cash & Marketable Securities
- $1.05B
- Total Debt
- $23.00K
- Net Cash
- $1.05B
- Net Cash Per Share
- $7.85
- Tangible Book Value Per Share
- $6.22
Margins
Gross margin is 85.26%, with operating margin of 48.97%, and net profit margin of 40.30%.
- Gross Margin
- 85.26%
- Operating Margin
- 48.97%
- Pretax Margin
- 50.50%
- Net Profit Margin
- 40.30%
- EBITDA Margin
- 52.83%
- EBIT Margin
- 48.97%